No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Benzylamines / metabolism
-
Benzylamines / pharmacology
-
Binding, Competitive / drug effects*
-
Binding, Competitive / physiology
-
Brain / drug effects
-
Brain / metabolism*
-
Cells, Cultured
-
Chickens
-
Citalopram / metabolism*
-
Citalopram / pharmacokinetics
-
Citalopram / pharmacology
-
Evolution, Molecular
-
Humans
-
Isoquinolines / metabolism
-
Isoquinolines / pharmacology
-
Ligands
-
Membrane Glycoproteins / drug effects*
-
Membrane Glycoproteins / genetics
-
Membrane Glycoproteins / metabolism
-
Membrane Transport Proteins / drug effects*
-
Membrane Transport Proteins / genetics
-
Membrane Transport Proteins / metabolism
-
Nerve Tissue Proteins / drug effects*
-
Nerve Tissue Proteins / genetics
-
Nerve Tissue Proteins / metabolism
-
Paroxetine / metabolism*
-
Paroxetine / pharmacokinetics
-
Paroxetine / pharmacology
-
Radioligand Assay
-
Rats
-
Selective Serotonin Reuptake Inhibitors / metabolism*
-
Selective Serotonin Reuptake Inhibitors / pharmacokinetics
-
Selective Serotonin Reuptake Inhibitors / pharmacology
-
Serotonin / metabolism
-
Serotonin Antagonists / metabolism
-
Serotonin Antagonists / pharmacology
-
Serotonin Plasma Membrane Transport Proteins
-
Sertraline / metabolism
-
Sertraline / pharmacology
-
Species Specificity
-
Tritium
Substances
-
Benzylamines
-
Isoquinolines
-
Ligands
-
Membrane Glycoproteins
-
Membrane Transport Proteins
-
N,N-dimethyl-2-(2-amino-4-methylphenylthio)benzylamine
-
Nerve Tissue Proteins
-
SLC6A4 protein, human
-
Serotonin Antagonists
-
Serotonin Plasma Membrane Transport Proteins
-
Serotonin Uptake Inhibitors
-
Slc6a4 protein, rat
-
Citalopram
-
Tritium
-
Serotonin
-
Paroxetine
-
McN 5652
-
Sertraline